You have 9 free searches left this month | for more free features.

aggressive-variant prostate carcinomas

Showing 1 - 25 of 8,211

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma Trial

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2022

Prostate Cancer Aggressiveness, Prostate Carcinoma Trial in Houston (Cabazitaxel, Carboplatin, Prednisone 5Mg)

Active, not recruiting
  • Prostate Cancer Aggressiveness
  • Prostate Carcinoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)

Not yet recruiting
  • Prostate Cancer
  • ADI-PEG 20
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 16, 2023

Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)

Not yet recruiting
  • Prostate Cancer Metastatic
  • (no location specified)
Sep 29, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

A Research Registry on Aggressive PitNETs

Recruiting
  • Endocrine Tumor
    • Lyon, France
      Hospices Civils de Lyon - Groupement Hospitalier Est
    Aug 4, 2023

    Analyzing Composition of Tears and Blood for Discovery of Novel

    Active, not recruiting
    • Prostate Cancer
      • Little Rock, Arkansas
        University of Arkansas for Medical Sciences
      Jan 6, 2023

      Prostate Cancer Trial in Fort-de-France (HOXB13 c.853delT mutation)

      Recruiting
      • Prostate Cancer
      • HOXB13 c.853delT mutation
      • Fort-de-France, Martinique
        Centre Hospitalier Universitaire de Martinique
      Aug 3, 2022

      Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

      Not yet recruiting
      • Localized Prostate Carcinoma
      • +3 more
      • Degarelix
      • MRI-guided transurethral ultrasound ablation (TULSA)
      • Turku, Southwest Finland, Finland
        Turku University Hospital
      Jun 14, 2023

      Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +

      Recruiting
      • Metastatic Castration-Resistant Prostate Cancer
      • XmAb20717 + carboplatin + cabazitaxel
      • +2 more
      • Duarte, California
      • +9 more
      May 24, 2022

      Prostate Cancer Trial in Detroit (Educational video)

      Not yet recruiting
      • Prostate Cancer
      • Educational video
      • Detroit, Michigan
        Henry Ford Cancer Pavilion
      Jul 14, 2023

      Epiction of Genomic and Genetic Landscape Identifies CCL5

      Completed
      • Colorectal Neuroendocrine Carcinomas (CRNEC); Genomic Landscape; Genetic Landscape; Prognosis; CCL5; PAX5
        • (no location specified)
        Jan 27, 2023

        Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))

        Active, not recruiting
        • Prostate Cancer
        • Multiparametric magnetic resonance imaging (mpMRI)
        • Taoyuan, Taiwan
          Li-Jen Wang
        Nov 9, 2023

        Prostate Cancer Trial in Washington (Proactive Streamlined Genetic Education and Testing, Usual Care)

        Completed
        • Prostate Cancer
        • Proactive Streamlined Genetic Education and Testing
        • Usual Care
        • Washington, District of Columbia
          Georgetown University Medical Center/Lombardi Comprehensive Canc
        Jan 4, 2023

        Prostate Cancer Trial in London

        Recruiting
        • Prostate Cancer
          • London, United Kingdom
            University College London
          Jul 28, 2022

          Prostate Active Surveillance Study

          Recruiting
          • Prostatic Neoplasms
            • San Francisco, California
            • +9 more
            Jul 5, 2022

            Decipher® Testing - VANDAAM Study

            Recruiting
            • Prostate Cancer
            • Decipher® Testing
            • Bay Pines, Florida
            • +2 more
            May 27, 2022

            Danish Prostate Cancer Consortium Study-1

            Recruiting
            • Prostate Cancer
              • Aarhus N, Aarhus, Denmark
              • +2 more
              Mar 1, 2023

              Prostate Carcinoma Trial in Los Angeles (procedure, device, other)

              Not yet recruiting
              • Prostate Carcinoma
              • Biospecimen Collection
              • +4 more
              • Los Angeles, California
                USC / Norris Comprehensive Cancer Center
              Nov 6, 2023

              Nevoid Basal Cell Carcinomas in Gorlin Syndrome

              Enrolling by invitation
              • Basal Cell Carcinoma
              • Gorlin Syndrome
              • Active surveillance
              • Oslo, Norway
                Oslo University Hospital
              Jun 8, 2023

              Needs and Preferences of Patients With Head-neck Cutaneous SCC

              Active, not recruiting
              • Cutaneous Squamous Cell Carcinoma
              • +10 more
              • Regular care with additional administration of a semi-structured interview
              • Maastricht, Netherlands
                Maastricht University Medical Center+
              Sep 13, 2023

              Treatment in Carriers of Rare Germline Mutations

              Recruiting
              • Prostate Cancer
                • Sutton, Surrey, United Kingdom
                  Institute of Cancer Research and Royal Marsden Hospital
                Mar 30, 2022

                Inherited Risk of Developing Aggressive Prostate Cancer, PATROL

                Recruiting
                • Prostate Carcinoma
                • Biospecimen Collection
                • +3 more
                • Seattle, Washington
                  Fred Hutch/University of Washington Cancer Consortium
                May 12, 2022

                Prostate Carcinoma Trial in United States (Multiparametric Magnetic Resonance Imaging)

                Recruiting
                • Prostate Carcinoma
                • Multiparametric Magnetic Resonance Imaging
                • Phoenix, Arizona
                • +43 more
                Jun 30, 2022